Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- Check7 days agoChange DetectedNew screenshot shows a UI redesign with updated layout and visuals, while all trial data (outcome measures, eligibility criteria, study dates, and recruitment status) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedAdded a government-status notice and version v3.2.0; removed the previous version v3.1.0.SummaryDifference7%

- Check43 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check57 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed; no changes to pricing, stock, or time slots.SummaryDifference0.4%

- Check64 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%

- Check71 days agoChange DetectedThe web page has undergone significant changes, including the removal of specific location details and regulatory study information, while also adding a facility name and a new revision number.SummaryDifference2%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.